🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Daniel S. Bejan

Oregon Health & Science University

ORCID: 0000-0002-5090-0299
Materials ScienceMedicineEngineering

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “The non-canonical target PARP16 contributes to polypharmacology of the PARP inhibitor talazoparib and its synergy with WEE1 inhibitors”.

The non-canonical target PARP16 contributes to polypharmacology of the PARP inhibitor talazoparib and its synergy with WEE1 inhibitors

Cell chemical biology(2021)10.1016/j.chembiol.2021.07.008
N/A
0DataRank · unranked
38 citations

Claire E. Knezevic, Daniel S. Bejan, Yunting Luo, Xueli Li, Silvia Novakova +10 more

Development of novel immunotherapy based on nanoparticle co-delivering PLK1 and PD-L1 inhibitors for lung cancer treatment

Research Square(2021)10.21203/rs.3.rs-142908/v1
N/A
0DataRank · unranked
2 citations

Worapol Ngamcherdtrakul, Natnaree Siriwon, Daniel S. Bejan, Sherif M. Reda, Ruijie Wang +8 more

Development of a nanoparticle-based immunotherapy targeting PD-L1 and PLK1 for lung cancer treatment

Nature Communications(2022)10.1038/s41467-022-31926-9
N/A
0DataRank · unranked
191 citations

Worapol Ngamcherdtrakul, Molly A. Nelson, Natnaree Siriwon, Ruijie Wang, Husam Y. Zaidan +10 more

Targeted Nanoparticle for Co‐delivery of HER2 siRNA and a Taxane to Mirror the Standard Treatment of HER2+ Breast Cancer: Efficacy in Breast Tumor and Brain Metastasis

Small(2022)10.1002/smll.202107550
N/A
0DataRank · unranked
48 citations

Daniel S. Bejan, William Cruz‐Muñoz, Moataz Reda, Husam Y. Zaidan, Natnaree Siriwon +8 more

Structurally distinct PARP7 inhibitors provide new insights into the function of PARP7 in regulating nucleic acid-sensing and IFN-β signaling

Cell chemical biology(2022)10.1016/j.chembiol.2022.11.012
N/A
0DataRank · unranked
43 citations

Kelsie M. Rodriguez, Daniel S. Bejan, Ninni Elise Olafsen, Inga D. Bohn, Ana Kojic +9 more

Allosteric regulation of DNA binding and target residence time drive the cytotoxicity of phthalazinone-based PARP-1 inhibitors

Cell chemical biology(2022)10.1016/j.chembiol.2022.11.006
N/A
0DataRank · unranked
11 citations

Marie-France Langelier, Jessica Gartrell, Ilsa T. Kirby, Daniel J. Sanderson, Daniel S. Bejan +9 more

Methods for profiling the target and off-target landscape of PARP inhibitors

Current Research in Chemical Biology(2022)10.1016/j.crchbi.2022.100027
N/A
0DataRank · unranked
7 citations

Michael S. Cohen, Daniel S. Bejan

Development of novel immunotherapy based on nanoparticle co-delivering PLK1 and PD-L1 inhibitors for lung cancer treatment

Research Square(2022)10.21203/rs.3.rs-142908/v2
N/A
0DataRank · unranked
0 citations

Worapol Ngamcherdtrakul, Molly A. Nelson, Natnaree Siriwon, Ruijie Wang, Husam Y. Zaidan +10 more

PARP14 is an interferon (IFN)-induced host factor that promotes IFN production and affects the replication of multiple viruses

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.04.26.591186
N/A
0DataRank · unranked
16 citations

Pradtahna Saenjamsai, Hongping Hao, Anna Ferkul, Jessica J. Pfannenstiel, Daniel S. Bejan +12 more

A family of E3 ligases extend K11 polyubiquitin on sites of MARUbylation

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.05.11.653360
N/A
0DataRank · unranked
6 citations

Kapil Upadhyaya, Jasleen Kaur Sidhu, Daniel S. Bejan, Ivan Rodriguez Siordia, Michael S. Cohen +2 more